Media-OutReach Newswire Case Study Highlights INDIBA 448 kHz Radiofrequency’s Role in Visceral Fat Reduction and Prevention of Fat Accumulation
Media-OutReach Newswire LANDMARK Unveils Lauren Tsai’s World Debut Installation "My Dream : Our Hill" for Hong Kong Arts Month
Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 2.